IGF-1, a powerful growth factor, exerts strong effects on each of the key stages of cancer development and higher levels of IGF-1 have been found to be associated with an increased disease risk, tumor metastasis and a poor prognosis in ovarian cancer via the activation of IGF1-R [16]. This evidence concerns the gene IGF1 and ovarian cancer.